Evelyn Mei Ling Goh

Development and validation of high‐performance liquid chromatography–tandem mass spectrometry assay for 6‐(3‐benzoyl‐ureido)‐hexanoic acid hydroxyamide, a novel HDAC inhibitor, in mouse plasma for pharmacokinetic studies

Pauline Yeo, Evelyn Mei Ling Goh, Lee Sun New et al. · Biomedical Chromatography · 2007 · 36 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Urinary Metabolite Biomarkers for the Detection of Synthetic Cannabinoid ADB-BUTINACA Abuse

Chi Hon Sia, Ziteng Wang, Evelyn Mei Ling Goh et al. · Clinical Chemistry · 2021 · 32 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

In Vitro Phase I Cytochrome P450 Metabolism, Permeability and Pharmacokinetics of SB639, a Novel Histone Deacetylase Inhibitor in Preclinical Species

Pilla Reddy Venkatesh, Evelyn Mei Ling Goh, Peizi Zeng et al. · Biological and Pharmaceutical Bulletin · 2007 · 28 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Diagnosing intake and rationalizing toxicities associated with 5F-MDMB-PINACA and 4F-MDMB-BINACA abuse

Wen Lie, Eleanor Jing Yi Cheong, Evelyn Mei Ling Goh et al. · Archives of Toxicology · 2020 · 27 citations · Full text

Pharmacy, Pharmacology, Toxicology +7

Preclinical Metabolism and Disposition of SB939 (Pracinostat), an Orally Active Histone Deacetylase Inhibitor, and Prediction of Human Pharmacokinetics

Ramesh Jayaraman, Venkatesh Pilla Reddy, Mohammad Pasha et al. · Drug Metabolism and Disposition · 2011 · 26 citations

Pharmacy, Pharmacokinetics, Pharmacology +17